Free Delivery Over $100
|
|
|||
|
||||
OverviewEngineering Technologies and Clinical Translation: Volume 3: Delivery Strategies and Engineering Technologies in Cancer Immunotherapy examines the challenges of delivering immuno-oncology therapies, focusing specifically on the development of solutions for drug delivery and its clinical outcomes. Immuno-oncology (IO) is a growing field of medicine at the interface of immunology and cancer biology leading to development of novel therapeutic approaches, such as chimeric antigen receptor T-cell (CAR-T) and immune checkpoint blockade antibodies, that are clinically approved approaches for cancer therapy. Although currently approved IO approaches have shown tremendous promise for select types of cancers, broad application of IO strategies could even further improve the clinical success, especially for diseases such as pancreatic cancer, brain tumors where the success of IO so far has been limited. This volume of Delivery Strategies and Engineering Technologies in Cancer Immunotherapy discusses biomaterial, microfluidic, and biodegradable devices, engineered microbes, personalized medicine, clinical approval process, and many other IO technologies. Engineering Technologies and Clinical Translation: Volume 3: Delivery Strategies and Engineering Technologies in Cancer Immunotherapy creates a comprehensive treaty that engages the scientific and medical community who are involved in the challenges of immunology, cancer biology, and therapeutics with possible solutions from the nanotechnology and drug delivery side. Full Product DetailsAuthor: Mansoor Amiji (Distinguished Professor and Chairman, Department of Pharmaceutical Sciences, School of Pharmacy, Bouve College of Health Sciences, Northeastern University, Boston, Massachusetts, USA) , Lara Milane (Assistant Teaching Professor in Biotechnology, Bouve College of Health Sciences, Northeastern University, USA)Publisher: Elsevier Science & Technology Imprint: Academic Press Inc Weight: 0.450kg ISBN: 9780323909495ISBN 10: 0323909493 Pages: 524 Publication Date: 27 August 2021 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand  We will order this item for you from a manufactured on demand supplier. Table of Contents1. Engineering solutions for generating CAR-T cells 2. Engineered microbes for cancer immunotherapy 3. Biodegradable scaffolds for priming the immune cells 4. Biomaterials and devices for immunotherapy 5. Engineered devices for tumor immune modulation 6. Microfluidic devices for cancer immunotherapy and vaccination 7. Tumor-on-a-chip devices for immunotherapy 8. Engineered 3D models for cancer immunotherapy 9. Opportunities and challenges of using nanotechnology for cancer immunotherapy 10. Stromal modulation to improve immunotherapy response in cancer 11. Mapping the tumor immune microenvironment 12. Personalized cancer immunotherapy 13. Image-guided cancer immunotherapy 14. Clinical approval process and challenges for cancer immunotherapiesReviewsAuthor InformationMansoor M. Amiji is the Distinguished Professor and Chairman of the Department of Pharmaceutical Sciences at the Bouve College of Health Sciences at Northeastern University. Dr. Amiji has edited a number of books and is a frequently published author. His research focuses on the synthesis of novel polymeric materials for medical and pharmaceutical applications, drug delivery systems and nanomedical technologies, and his contributions in research advising, grant reviews for various organizations and editorial work for journals are invaluable. Dr. Lara Milane is Assistant Teaching Professor in Biotechnology at the Bouve College of Health Sciences at Northeastern University. She is interested in Mitochondrial Medicine. She is working on developing nanomedicines for a range of diseases (cancer, neurodegenerative disease, aging) that manipulate mitochondria for therapeutic outcomes. Dr. Milane was trained as a National Cancer Institute/ National Science Foundation Nanomedicine Fellow at Northeastern University, Boston, MA. Dr. Milane is an intuitive cancer biologist with research interests in developing translational nanomedicines that exploit the hallmarks of cancer.? Tab Content 6Author Website:Countries AvailableAll regions |
||||
